PBSV
Pharma-Bio Serv, Inc.
-0.05 (-11.11%)0.40USD1.5K成交股數9.2M市值36.4本益比(近四季)1.0股價營收比+19.0%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 10 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 24Q1 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 2.3M-3% | 2.7M+9% | 2.3M | 2.0M-19% | 2.4M+2% | 2.5M+4% | – | 2.4M-47% | 2.4M | 2.4M | – | 4.6M |
| 營業成本 | 1.6M | 1.8M | 1.6M | 1.4M | 1.6M | 1.7M | – | 1.8M | 1.8M | 1.8M | – | 3.0M |
| 毛利 | 692K-16% | 902K+17% | 722K | 574K-10% | 819K+32% | 768K+43% | – | 635K-59% | 618K | 536K | – | 1.6M |
| 毛利率 | 29.6% | 33.4% | 31.5% | 29.3% | 33.9% | 31.1% | – | 26.3% | 26.0% | 22.5% | – | 33.9% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 764K | 757K | 817K | 888K | 917K | 860K | – | 1.0M | 932K | 974K | – | 1.1M |
| 營業利益 | −72K-27% | 145K-257% | −95K | −314K-18% | −98K-69% | −92K-79% | – | −382K-183% | −313K | −438K | – | 460K |
| 營業利益率 | -3.1% | 5.4% | -4.1% | -16.0% | -4.1% | -3.7% | – | -15.8% | -13.2% | -18.4% | – | 10.1% |
| 稅後淨利 | −14K-115% | 233K+2629% | 33K | −204K-34% | 95K-145% | 9K-103% | – | −309K-159% | −214K | −271K | – | 526K |
| 淨利率 | -0.6% | 8.6% | 1.4% | -10.4% | 3.9% | 0.3% | – | -12.8% | -9.0% | -11.4% | – | 11.5% |
| 稀釋 EPS | -0.00-125% | 0.01 | 0.00 | -0.01-164% | 0.00-144% | 0.00-100% | – | 0.01 | -0.01 | -0.01 | – | – |
| 稀釋股數 | 22.9M | 22.9M | 22.9M | 22.9M | 22.9M | 23.0M | – | 23.0M | 23.0M | 23.0M | – | 23.0M |
資產負債表 期末餘額
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 24Q1 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 1.5M | 1.8M | 5.8M | 4.0M | 2.1M | 7.3M | – | 6.5M | 3.5M | 6.4M | – | 2.9M |
| 應收帳款 | 2.4M | 2.7M | 2.7M | 2.0M | 2.7M | 2.7M | – | 2.6M | 2.6M | 2.4M | – | 4.6M |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 11.4M | 11.5M | 13.5M | 13.6M | 13.9M | 16.1M | – | 16.3M | 16.9M | 19.2M | – | 20.3M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 995K | 1.0M | 3.3M | 1.7M | 1.8M | 4.1M | – | 2.6M | 3.0M | 5.1M | – | 4.1M |
| 股東權益 | 10.4M | 10.5M | 10.2M | 11.9M | 12.1M | 12.0M | – | 13.7M | 14.0M | 14.2M | – | 16.2M |
| 負債比 | 8.7% | 9.1% | 24.4% | 12.2% | 12.8% | 25.4% | – | 16.1% | 17.6% | 26.4% | – | 20.3% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 24Q1 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | 61K-120% | −365K-15% | −390K | 237K-135% | −302K-57% | −429K-159% | – | −670K-170% | −701K | 726K | – | 957K |
| 資本支出 | 1K | 2K | 2K | 2K | 4K | 0.00 | – | 2K | 0.00 | 820.00 | – | 0.00 |
| 自由現金流 | 60K-119% | −368K-14% | −393K | 234K-135% | −306K-56% | −429K-159% | – | −672K-170% | −701K | 725K | – | 957K |
| 折舊攤銷 | 14K | 14K | 15K | 16K | 19K | 9K | – | 5K | 6K | 7K | – | 11K |
| 買回庫藏股 | 0.00 | 709.00 | 2K | 5K | 17K | 0.00 | – | 2K | 2K | 7K | – | 5K |
| 現金股利 | 0.00 | 1.7M | – | 0.00 | 1.7M | – | 1.7M | 0.00 | 1.7M | 1.7M | 1.7M | 0.00 |
| 自由現金流率 | 2.5% | -13.6% | -17.1% | 11.9% | -12.7% | -17.4% | – | -27.8% | -29.5% | 30.5% | – | 20.9% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 9.0M
| Puerto Rico Consulting | 4.6M | 51.5% | -18.5% |
|---|---|---|---|
| United States Consulting | 2.6M | 29.1% | -17.1% |
| Europe Consulting | 1.7M | 19.2% | +202.4% |
| 其他 | 17K | 0.2% | -80.6% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 9.0M | -5.3% | −100K | -1.1% | -0.00 | −222K |
| FY2024 | 9.5M | -44.0% | −778K | -8.2% | -0.03 | −726K |
| FY2023 | 17.0M | -12.5% | 1.3M | 7.7% | 0.06 | 1.9M |
| FY2022 | 19.4M | -3.6% | 1.0M | 5.2% | – | 573K |
| FY2021 | 20.1M | -6.7% | −2.1M | -10.4% | – | 794K |
| FY2020 | 21.6M | +10.5% | 2.1M | 9.5% | 0.09 | 1.5M |
| FY2019 | 19.5M | +9.6% | 2.1M | 10.7% | 0.09 | −2.3M |
| FY2018 | 17.8M | – | 1.3M | 7.2% | – | 3.6M |